Research output per year
Research output per year
Personal profile
Research
My research group investigates how the immune system affects heart disease and investigates immunomodulatory therapies.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Daniel Engelbertsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis
Singh, P., Sun, J., Cavalera, M., Al-Sharify, D., Matthes, F., Barghouth, M., Tengryd, C., Dunér, P., Persson, A., Sundius, L., Nitulescu, M., Bengtsson, E., Rattik, S., Engelbertsen, D., Orho-Melander, M., Nilsson, J., Monaco, C., Goncalves, I. & Edsfeldt, A., 2024 Dec, In: Nature Communications. 15, p. 1-18 10464.Research output: Contribution to journal › Article › peer-review
Open Access -
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients: a cohort study
Zhong, B., King, B., Waziri, H., Yndigegn, T., Engelbertsen, D., Björkbacka, H., Nilsson, J., Goncalves, I., Blom, A. M. & Schiopu, A., 2024 Dec, In: Journal of Translational Medicine. 22, 1, 1011.Research output: Contribution to journal › Article › peer-review
Open Access -
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
Mulholland, M., Depuydt, M. A. C., Jakobsson, G., Ljungcrantz, I., Grentzmann, A., To, F., Bengtsson, E., Jaensson Gyllenbäck, E., Grönberg, C., Rattik, S., Liberg, D., Schiopu, A., Björkbacka, H., Kuiper, J., Bot, I., Slütter, B. & Engelbertsen, D., 2024, In: Cardiovascular Research. 120, 6, p. 581-595Research output: Contribution to journal › Article › peer-review
Open Access -
Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study
Tomas, L., Katra, P., Badn, W., Andersson, L., Nilsson, J., Schiopu, A., Engelbertsen, D., Gonçalves, I., Bengtsson, E. & Björkbacka, H., 2023 Nov 1, In: European Heart Journal Open. 3, 6, oead094.Research output: Contribution to journal › Article › peer-review
Open Access -
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
Katra, P., Hennings, V., Nilsson, J., Engström, G., Engelbertsen, D., Bengtsson, E. & Björkbacka, H., 2023 Feb, In: Atherosclerosis. 366, p. 1-7Research output: Contribution to journal › Article › peer-review
Open Access
-
B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVD
Björkbacka, H. (PI) & Engelbertsen, D. (PI)
European Commission - Horizon Europe
2023/10/01 → 2027/09/30
Project: Research
-
Immune checkpoint regulation of T cells in atherosclerosis
Chalou, A. (Researcher), Engelbertsen, D. (Supervisor) & Björkbacka, H. (Assistant supervisor)
2023/09/08 → …
Project: Dissertation
-
Mechanistic and therapeutic studies on the role of the S100A9 alarmin in cardiac inflammation
Jakobsson, G. (Researcher), Schiopu, A. (Supervisor) & Engelbertsen, D. (Assistant supervisor)
2020/07/01 → 2024/07/01
Project: Dissertation
-
Mechanisms of T-cell mediated aggravation of atherosclerosis
Engelbertsen, D. (Researcher)
The Swedish Heart Lung Foundation, Magnus Bergvalls Stiftelse
2017/01/01 → 2023/12/31
Project: Research